CWBR: CohBar, Inc. - Summary | Jitta

CohBar, Inc.

NASDAQ:CWBR

Notice
Stock data is unavailable or the company’s delisted.
Price
$0.41
Loss Chance
58.4%
0.95JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (5)
Recent Business Performance (14)
Financial Strength (35)
Return to Shareholders (0)
Competitive Advantage (9)
Jitta Signs
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 74.20% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.95
100.00%
2.22
139.24%
3.06
206.98%
Biotechnology
5.52
234.03%
6.26
56.19%
5.05
11.22%
COMPANY DESCRIPTION
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.